These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 7641020

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. (99m)Tc-sestamibi scanning in thyroid nodules with nondiagnostic cytology.
    Giovanella L, Suriano S, Maffioli M, Ceriani L, Spriano G.
    Head Neck; 2010 May; 32(5):607-11. PubMed ID: 19693945
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The value of Tc-99m tetrofosmin thyroid scintigraphy in patients with nodular goiter.
    Karayalçin U, Ciftçi F, Boz A, Boz S, Karayalçin B.
    Ann Nucl Med; 1997 Nov; 11(4):285-90. PubMed ID: 9460519
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Preoperative imaging of abnormal parathyroid glands in patients with hyperparathyroid disease using combination Tc-99m-pertechnetate and Tc-99m-sestamibi radionuclide scans.
    Wei JP, Burke GJ, Mansberger AR.
    Ann Surg; 1994 May; 219(5):568-72; discussion 572-3. PubMed ID: 8185405
    [Abstract] [Full Text] [Related]

  • 11. Thyroid remnant estimation by Tc-99m-sestamibi scanning predicts the effectiveness of rhTSH-stimulated I-131 ablation in patients with differentiated thyroid carcinoma.
    Giovanella L, Suriano S, Castellani M, Ceriani L, Verburg FA.
    Clin Nucl Med; 2011 Sep; 36(9):781-5. PubMed ID: 21825849
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tc-99m sestamibi thyroid imaging in patients on chronic amiodarone treatment: a comparison with Tc-99m pertechnetate imaging.
    Oki GC, Zantut-Wittmann DE, de Oliveira Santos A, Guariento MH, Tambascia MA, de Almeida EA, Amorim BJ, Lima MC, Etchebehere EC, Camargo EE, Ramos CD.
    Clin Nucl Med; 2010 Apr; 35(4):223-7. PubMed ID: 20305407
    [Abstract] [Full Text] [Related]

  • 14. Radionuclide thyroid angiography and surgical correlation. A five-year study.
    Moe RD, Frankel SF, Chacko AK, Yim DW, Clark MW.
    Arch Otolaryngol; 1984 Nov; 110(11):717-20. PubMed ID: 6091597
    [Abstract] [Full Text] [Related]

  • 15. Tc-99m sestamibi parathyroid gland scintigraphy: added value of Tc-99m pertechnetate thyroid imaging for increasing interpretation confidence and avoiding additional testing.
    Powell DK, Nwoke F, Goldfarb RC, Ongseng F.
    Clin Imaging; 2013 Nov; 37(3):475-9. PubMed ID: 23102932
    [Abstract] [Full Text] [Related]

  • 16. Differentiation of benign from malignant nodules by accumulation of Tc-99m pertechnetate using TI-201 delayed scans.
    Okumura Y, Takeda Y, Sato S, Shimizu M, Komatsu M, Honda O, Nakagawa T, Niiya H, Hiraki Y.
    Clin Nucl Med; 1998 Aug; 23(8):514-6. PubMed ID: 9712383
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
    Lind P, Gallowitsch HJ.
    Acta Med Austriaca; 1996 Aug; 23(1-2):69-75. PubMed ID: 8767519
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Papillary thyroid carcinoma associated with parathyroid adenoma detected by pertechnetate-MIBI subtraction scintigraphy.
    Rubello D, Toniato A, Pelizzo MR, Casara D.
    Clin Nucl Med; 2000 Nov; 25(11):898-900. PubMed ID: 11079587
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.